339-499-9300. Contact us to update your basic listing.Gain visibility and brand your listing with a directory sponsorship.bluebird bio develops gene therapies and cancer immunotherapies for the treatment of genetic diseases and cancer.
Have a question about who we are or what we do? 60 Binney St. Cambridge, MA 02142. Working at bluebird bio is somewhere between a career and a calling. Learn more at bluebirdbio.com. & DURHAM, N.C.--(BUSINESS WIRE)--Mar. CAMBRIDGE, Mass. Headquartered in Cambridge, MA, bluebird bio develops pioneering gene therapies for severe genetic diseases and cancers. We take what we do seriously, but make sure we have fun doing it.
All rights reservedLife Science Intelligence at NCBiotech strives to provide accurate and current data on the bioscience community in North Carolina. At its Durham site, bluebird produces lentiviral vectors for the company's gene and cell therapies. "Help NCBiotech keep the directory current and accurate.
Our objective is to develop and bring to market the most advanced products based on the transformative potential of gene therapy to provide patients hope for a better life in the face of limited or no long-term safe and effective treatment options.
You may reproduce the NCBiotech Company Directory site content for any legal purpose with proper attribution.
Search job openings, see if they fit - company salaries, reviews, and more posted by bluebird bio employees. We’re 800+ do-ers, thinkers and collaborators who find pride and enjoyment in working together to bring the promise of gene therapy to the people who need it. Attribution shall take the following form: "Data provided by the North Carolina Biotechnology Center, www.ncbiotech.org. bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. At its Durham site, bluebird produces lentiviral vectors for the company's gene and cell therapies.
From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully.
© 2018 North Carolina Biotechnology Center. We are here to help! At bluebird bio, we’re pushing hard on gene therapy because we believe it delivers the chance for people with severe genetic diseases and cancer to live fully, regardless of what’s written in their DNA.
bluebird, which develops gene and cell therapies for severe genetic diseases and T cell-based immunotherapies for cancer, is making investments in manufacturing infrastructure to … 22, 2019-- bluebird bio, Inc. (Nasdaq: BLUE) today announced the official opening of its first wholly owned manufacturing facility in Durham, N.C., that will produce lentiviral vector for the company’s investigational gene and cell therapies, including: bb2121 and bb21217 for the treatment of multiple myeloma and potentially LentiGlobin™ …
16 bluebird bio jobs in Durham, NC. We’re doing the hard work because people facing these challenges deserve it. Get in touch today to learn more.bluebird bio is a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies.
Headquartered in Cambridge, Massachusetts, bluebird bio has operations in the U.S. and Europe. bluebird bio Inc. bluebird bio develops gene therapies and cancer immunotherapies for the treatment of genetic diseases and cancer.